Rationale and protocol for the efficacy, safety and tolerability of nangibotide in patients with septic shock (ASTONISH) phase IIb randomised controlled trial

INTRODUCTION: Septic shock is the subgroup of patients with sepsis, which presents as vasopressor dependence, an elevated blood lactate concentration and is associated with a mortality of at least 30%. Expression of the triggering receptor expressed on myeloid cells 1 (TREM-1) pathway, measured usin...

Descripción completa

Detalles Bibliográficos
Autores principales: Francois, Bruno, Lambden, Simon, Gibot, Sebastien, Derive, Marc, Olivier, Aurelie, Cuvier, Valerie, Witte, Stephan, Grouin, Jean-Marie, Garaud, Jean Jacques, Salcedo-Magguilli, Margarita, Levy, Mitchell, Laterre, Pierre-François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Intensive Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264912/
https://www.ncbi.nlm.nih.gov/pubmed/34233965
http://dx.doi.org/10.1136/bmjopen-2020-042921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264912/
https://www.ncbi.nlm.nih.gov/pubmed/34233965
http://dx.doi.org/10.1136/bmjopen-2020-042921

Ejemplares similares